tiprankstipranks
Advertisement
Advertisement

PCCEPHE Stock Latest News

Cepheid Showcases Molecular Diagnostics Portfolio at NZIMLS Annual Meeting
Private CompaniesCepheid Showcases Molecular Diagnostics Portfolio at NZIMLS Annual Meeting
7m ago
CEPHE
Rapid Molecular Surveillance Study Highlights Potential Hospital Efficiency Gains
PremiumPrivate Companies
Rapid Molecular Surveillance Study Highlights Potential Hospital Efficiency Gains
3d ago
CEPHE
Cepheid Introduces RADAR Platform to Enhance Molecular Diagnostic Reliability
PremiumPrivate Companies
Cepheid Introduces RADAR Platform to Enhance Molecular Diagnostic Reliability
6d ago
CEPHE
Cepheid Advances Next-Generation GeneXpert and Public Health Focus in Busy Week
PremiumPrivate Companies
Cepheid Advances Next-Generation GeneXpert and Public Health Focus in Busy Week
15d ago
CEPHE
Cepheid Highlights Role of Point-of-Care HCV Testing in Hepatitis Elimination Efforts
PremiumPrivate Companies
Cepheid Highlights Role of Point-of-Care HCV Testing in Hepatitis Elimination Efforts
18d ago
CEPHE
Cepheid Showcases Next-Generation GeneXpert Platform at ADLM
PremiumPrivate CompaniesCepheid Showcases Next-Generation GeneXpert Platform at ADLM
18d ago
CEPHE
Cepheid Emphasizes Molecular Diagnostics Role in Global Hepatitis Care
Premium
Private Companies
Cepheid Emphasizes Molecular Diagnostics Role in Global Hepatitis Care
19d ago
CEPHE
Cepheid Showcases Rapid Infectious Disease Diagnostics at Dublin User Event
Premium
Private Companies
Cepheid Showcases Rapid Infectious Disease Diagnostics at Dublin User Event
20d ago
CEPHE
Community-Based Hepatitis C Care Underscores Demand for Point-of-Care Testing
PremiumPrivate Companies
Community-Based Hepatitis C Care Underscores Demand for Point-of-Care Testing
20d ago
CEPHE
Cepheid Advances Next-Generation GeneXpert and Syndromic Strategy Ahead of ADLM 2026
PremiumPrivate Companies
Cepheid Advances Next-Generation GeneXpert and Syndromic Strategy Ahead of ADLM 2026
22d ago
CEPHE
Focus on Respiratory Diagnostic Precision Highlights Cepheid’s Strategic Positioning
PremiumPrivate Companies
Focus on Respiratory Diagnostic Precision Highlights Cepheid’s Strategic Positioning
23d ago
CEPHE
Diagnostics Emphasis Positions Cepheid Within Global Antimicrobial Resistance Efforts
PremiumPrivate Companies
Diagnostics Emphasis Positions Cepheid Within Global Antimicrobial Resistance Efforts
24d ago
CEPHE
Cepheid Previews Next-Generation GeneXpert System Targeting Advanced Molecular Diagnostics
PremiumPrivate CompaniesCepheid Previews Next-Generation GeneXpert System Targeting Advanced Molecular Diagnostics
25d ago
CEPHE
Cepheid’s Third-Generation GeneXpert Targets Broader, Faster Molecular Testing
Premium
Private Companies
Cepheid’s Third-Generation GeneXpert Targets Broader, Faster Molecular Testing
25d ago
CEPHE
Cepheid Targets Growth Opportunities With New Diagnostics Platforms at ADLM2026
Premium
Private Companies
Cepheid Targets Growth Opportunities With New Diagnostics Platforms at ADLM2026
26d ago
CEPHE
Cepheid Highlights Diagnostic Platform Advancements and Syndromic Expansion at ADLM 2026
PremiumPrivate Companies
Cepheid Highlights Diagnostic Platform Advancements and Syndromic Expansion at ADLM 2026
27d ago
CEPHE
Policy Engagement Underscores Strategic Role of Cepheid’s Bothell Diagnostics Hub
PremiumPrivate Companies
Policy Engagement Underscores Strategic Role of Cepheid’s Bothell Diagnostics Hub
1M ago
CEPHE
Cepheid Highlights Diagnostic Capabilities Ahead of ADLM 2026
PremiumPrivate Companies
Cepheid Highlights Diagnostic Capabilities Ahead of ADLM 2026
1M ago
CEPHE
Cepheid – Weekly Recap
PremiumPrivate Companies
Cepheid – Weekly Recap
1M ago
CEPHE
Cepheid Participates in AMR Study on Rapid Molecular Screening for CPE
PremiumPrivate CompaniesCepheid Participates in AMR Study on Rapid Molecular Screening for CPE
1M ago
CEPHE
Cepheid Highlights Design-Focused Approach to GI Panel Diagnostics
Premium
Private Companies
Cepheid Highlights Design-Focused Approach to GI Panel Diagnostics
1M ago
CEPHE
Cepheid Study Shows Xpert Xpress MVP Sharply Improves Vaginitis Treatment Decisions
Premium
Private Companies
Cepheid Study Shows Xpert Xpress MVP Sharply Improves Vaginitis Treatment Decisions
1M ago
CEPHE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >